ADC Services

Discover comprehensive Antibody-drug conjugates (ADCs) solutions

Antibody-drug conjugation technology uses monoclonal antibodies (mAbs) to deliver potent, highly active pharmaceutical ingredients (HPAPIs) to targeted cells. In conjugated form, HPAPIs exhibit selective cytotoxicity which help spare non-target cells from toxic effects, thereby improving the overall safety profile of the therapy for the patient.

The complex nature of an ADC requires expertise in small and large molecule development, manufacturing, formulation and testing.

Choosing an experienced partner with these skills and the required containment facilities will advance your ADC to market. Whether you are looking to build your process based on our tailored technology platforms or need a service provider—or maybe even both—we can collaborate with you.